During the past decade, Cardiovascular Solutions Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Solutions Institute" are "Peripheral Arterial Disease" (1 trials) and "Symptomatic Vascular Disease of the Iliac Arteries" (1 trials). Many other conditions were trialed in "Cardiovascular Solutions Institute" in a lesser frequency.

Most popular intervention types in "Cardiovascular Solutions Institute" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "BioMimics 3D Vascular Stent System" (1 trials) and "Formula™ 535 Iliac Balloon-Expandable Stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Solutions Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular Solutions Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cardiovascular Solutions Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Solutions Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".